287 related articles for article (PubMed ID: 31555257)
1. The Contribution of Gut Barrier Changes to Multiple Sclerosis Pathophysiology.
Buscarinu MC; Fornasiero A; Romano S; Ferraldeschi M; Mechelli R; Reniè R; Morena E; Romano C; Pellicciari G; Landi AC; Salvetti M; Ristori G
Front Immunol; 2019; 10():1916. PubMed ID: 31555257
[TBL] [Abstract][Full Text] [Related]
2. The Gut-Brain Axis in Multiple Sclerosis. Is Its Dysfunction a Pathological Trigger or a Consequence of the Disease?
Parodi B; Kerlero de Rosbo N
Front Immunol; 2021; 12():718220. PubMed ID: 34621267
[TBL] [Abstract][Full Text] [Related]
3. Alterations in Circulating Fatty Acid Are Associated With Gut Microbiota Dysbiosis and Inflammation in Multiple Sclerosis.
Saresella M; Marventano I; Barone M; La Rosa F; Piancone F; Mendozzi L; d'Arma A; Rossi V; Pugnetti L; Roda G; Casagni E; Cas MD; Paroni R; Brigidi P; Turroni S; Clerici M
Front Immunol; 2020; 11():1390. PubMed ID: 32733460
[No Abstract] [Full Text] [Related]
4. The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics.
Camara-Lemarroy CR; Metz L; Meddings JB; Sharkey KA; Wee Yong V
Brain; 2018 Jul; 141(7):1900-1916. PubMed ID: 29860380
[TBL] [Abstract][Full Text] [Related]
5. Intestinal Permeability in Relapsing-Remitting Multiple Sclerosis.
Buscarinu MC; Romano S; Mechelli R; Pizzolato Umeton R; Ferraldeschi M; Fornasiero A; Reniè R; Cerasoli B; Morena E; Romano C; Loizzo ND; Umeton R; Salvetti M; Ristori G
Neurotherapeutics; 2018 Jan; 15(1):68-74. PubMed ID: 29119385
[TBL] [Abstract][Full Text] [Related]
6. The role of gut microbiome and associated metabolome in the regulation of neuroinflammation in multiple sclerosis and its implications in attenuating chronic inflammation in other inflammatory and autoimmune disorders.
Dopkins N; Nagarkatti PS; Nagarkatti M
Immunology; 2018 Jun; 154(2):178-185. PubMed ID: 29392733
[TBL] [Abstract][Full Text] [Related]
7. Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders.
Chopyk DM; Grakoui A
Gastroenterology; 2020 Sep; 159(3):849-863. PubMed ID: 32569766
[TBL] [Abstract][Full Text] [Related]
8.
Zhang H; Liu M; Liu X; Zhong W; Li Y; Ran Y; Guo L; Chen X; Zhao J; Wang B; Zhou L
Front Immunol; 2020; 11():569104. PubMed ID: 33123141
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota, cannabinoid system and neuroimmune interactions: New perspectives in multiple sclerosis.
Mestre L; Carrillo-Salinas FJ; Mecha M; Feliú A; Guaza C
Biochem Pharmacol; 2018 Nov; 157():51-66. PubMed ID: 30171835
[TBL] [Abstract][Full Text] [Related]
10. Assessment of mucosal integrity by quantifying neutrophil granulocyte influx in murine models of acute intestinal injury.
Fischer JC; Wintges A; Haas T; Poeck H
Cell Immunol; 2017 Jun; 316():70-76. PubMed ID: 28413062
[TBL] [Abstract][Full Text] [Related]
11. Targeting the gut to treat multiple sclerosis.
Ghezzi L; Cantoni C; Pinget GV; Zhou Y; Piccio L
J Clin Invest; 2021 Jul; 131(13):. PubMed ID: 34196310
[TBL] [Abstract][Full Text] [Related]
12. Does the Gut Microbiota Influence Immunity and Inflammation in Multiple Sclerosis Pathophysiology?
Adamczyk-Sowa M; Medrek A; Madej P; Michlicka W; Dobrakowski P
J Immunol Res; 2017; 2017():7904821. PubMed ID: 28316999
[No Abstract] [Full Text] [Related]
13. Gut microbiome and multiple sclerosis: New insights and perspective.
Esmaeil Amini M; Shomali N; Bakhshi A; Rezaei S; Hemmatzadeh M; Hosseinzadeh R; Eslami S; Babaie F; Aslani S; Torkamandi S; Mohammadi H
Int Immunopharmacol; 2020 Nov; 88():107024. PubMed ID: 33182024
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory arthritis disrupts gut resolution mechanisms, promoting barrier breakdown by Porphyromonas gingivalis.
Flak MB; Colas RA; Muñoz-Atienza E; Curtis MA; Dalli J; Pitzalis C
JCI Insight; 2019 Jul; 4(13):. PubMed ID: 31292292
[TBL] [Abstract][Full Text] [Related]
15. IFN-γ, IL-17A, or zonulin rapidly increase the permeability of the blood-brain and small intestinal epithelial barriers: Relevance for neuro-inflammatory diseases.
Rahman MT; Ghosh C; Hossain M; Linfield D; Rezaee F; Janigro D; Marchi N; van Boxel-Dezaire AHH
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):274-279. PubMed ID: 30449598
[TBL] [Abstract][Full Text] [Related]
16. Loss of gut barrier integrity triggers activation of islet-reactive T cells and autoimmune diabetes.
Sorini C; Cosorich I; Lo Conte M; De Giorgi L; Facciotti F; Lucianò R; Rocchi M; Ferrarese R; Sanvito F; Canducci F; Falcone M
Proc Natl Acad Sci U S A; 2019 Jul; 116(30):15140-15149. PubMed ID: 31182588
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Fructo-Oligosaccharides on Gut Permeability and Inflammatory Responses in the Cecal Mucosa Quite Differs between Rats Fed Semi-Purified and Non-Purified Diets.
Genda T; Kondo T; Hino S; Sugiura S; Nishimura N; Morita T
J Nutr Sci Vitaminol (Tokyo); 2018; 64(5):357-366. PubMed ID: 30381626
[TBL] [Abstract][Full Text] [Related]
18. Serotonin: A mediator of the gut-brain axis in multiple sclerosis.
Malinova TS; Dijkstra CD; de Vries HE
Mult Scler; 2018 Aug; 24(9):1144-1150. PubMed ID: 29117778
[TBL] [Abstract][Full Text] [Related]
19. Intestinal Immune Dysregulation Driven by Dysbiosis Promotes Barrier Disruption and Bacterial Translocation in Rats With Cirrhosis.
Muñoz L; Borrero MJ; Úbeda M; Conde E; Del Campo R; Rodríguez-Serrano M; Lario M; Sánchez-Díaz AM; Pastor O; Díaz D; García-Bermejo L; Monserrat J; Álvarez-Mon M; Albillos A
Hepatology; 2019 Sep; 70(3):925-938. PubMed ID: 30414342
[TBL] [Abstract][Full Text] [Related]
20. Emerging Concepts on the Gut Microbiome and Multiple Sclerosis.
Glenn JD; Mowry EM
J Interferon Cytokine Res; 2016 Jun; 36(6):347-57. PubMed ID: 27145057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
